◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0648

SoftMedx Healthcare Limited (0648) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-10

SoftMedx Healthcare Limited (0648) operates in the Medical Care Facilities industry and is headquartered in Wan Chai, Hong Kong with about 20 employees. Its market capitalization is roughly HKD 63 million. In the fiscal year ended 2025-12-31, 0648 reported HKD 68M in revenue and HKD 7M in net income.

SoftMedx Healthcare Limited, an investment holding company, through its subsidiary, Wah Yan Bright Healthcare Limited, engages in the medical and well-being business for distribution of medical and healthcare equipment and products in Hong Kong.

Interactive charts & full statements →

0648 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueHKD 68MHKD 55MHKD 51MHKD 34M
Gross ProfitHKD 23MHKD 18MHKD 21MHKD 14M
Operating Income (EBIT)HKD 12MHKD 9MHKD 6M(HKD 9M)
Net IncomeHKD 7MHKD 326MHKD 12M(HKD 19M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0648 Free Cash Flow History

0648 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsHKD 49MHKD 55MHKD 56MHKD 25M
Total LiabilitiesHKD 21MHKD 52MHKD 380MHKD 369M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0648 viewer.

Other Companies in Medical Care Facilities

← 0646All “0-9” companies0650 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.